These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22295250)

  • 1. Expression of toll-like receptors on breast tumors: taking a toll on tumor microenvironment.
    Bhattacharya D; Yusuf N
    Int J Breast Cancer; 2012; 2012():716564. PubMed ID: 22295250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion.
    Yang H; Zhou H; Feng P; Zhou X; Wen H; Xie X; Shen H; Zhu X
    J Exp Clin Cancer Res; 2010 Jul; 29(1):92. PubMed ID: 20618976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of toll-like receptors: From inflammation to lung cancer progression.
    Gu J; Liu Y; Xie B; Ye P; Huang J; Lu Z
    Biomed Rep; 2018 Feb; 8(2):126-132. PubMed ID: 29435270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene silencing of Toll-like receptor 2 inhibits proliferation of human liver cancer cells and secretion of inflammatory cytokines.
    Huang Y; Cai B; Xu M; Qiu Z; Tao Y; Zhang Y; Wang J; Xu Y; Zhou Y; Yang J; Han X; Gao Q
    PLoS One; 2012; 7(7):e38890. PubMed ID: 22815694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.
    Basith S; Manavalan B; Yoo TH; Kim SG; Choi S
    Arch Pharm Res; 2012 Aug; 35(8):1297-316. PubMed ID: 22941474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression.
    Giurini EF; Madonna MB; Zloza A; Gupta KH
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment.
    Zheng R; Ma J
    Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis.
    Khajeh Alizadeh Attar M; Anwar MA; Eskian M; Keshavarz-Fathi M; Choi S; Rezaei N
    Med Res Rev; 2018 Sep; 38(5):1469-1484. PubMed ID: 29283184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations Between Serum Soluble Toll-like Receptors 4 and 9 and Breast Cancer in Egyptian Patients.
    Moaz I; Fouad FA; Elmasry H; Tarek G; Elzoheiry A; Elgamal M; Ibrahim R; Hisham Y; Safwat G; Kamel MM; El-Batal HM; Fouda M
    Cancer Control; 2023; 30():10732748231204755. PubMed ID: 37771087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor (TLR) expression of immune system cells from metastatic breast cancer patients with circulating tumor cells.
    Green TL; Santos MF; Ejaeidi AA; Craft BS; Lewis RE; Cruse JM
    Exp Mol Pathol; 2014 Aug; 97(1):44-8. PubMed ID: 24836676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-Like Receptors Signaling in the Tumor Microenvironment.
    McCall KD; Muccioli M; Benencia F
    Adv Exp Med Biol; 2020; 1223():81-97. PubMed ID: 32030686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Toll-Like Receptors in Hematopoietic Malignancies.
    Monlish DA; Bhatt ST; Schuettpelz LG
    Front Immunol; 2016; 7():390. PubMed ID: 27733853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profile of Toll‑like receptors in human breast cancer.
    Shi S; Xu C; Fang X; Zhang Y; Li H; Wen W; Yang G
    Mol Med Rep; 2020 Feb; 21(2):786-794. PubMed ID: 31789409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 3: implications for proinflammatory microenvironment in human breast cancer.
    Amarante MK; de Oliveira KB; Guembarovski RL; da Silva do Amaral Herrera AC; Guembarovski AL; Sobrinho WJ; Voltarelli JC; Watanabe MA
    Mol Biol Rep; 2012 Dec; 39(12):11087-92. PubMed ID: 23053995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual character of Toll-like receptor signaling: pro-tumorigenic effects and anti-tumor functions.
    Yu L; Wang L; Chen S
    Biochim Biophys Acta; 2013 Apr; 1835(2):144-54. PubMed ID: 23232186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLRs: linking inflammation and breast cancer.
    Bhatelia K; Singh K; Singh R
    Cell Signal; 2014 Nov; 26(11):2350-7. PubMed ID: 25093807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Toll-Like Receptor in Inflammation and Tumor Immunity.
    Cen X; Liu S; Cheng K
    Front Pharmacol; 2018; 9():878. PubMed ID: 30127747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of expression of toll-like receptors 2, 3 and 4 in laryngeal carcinoma.
    Szczepański M; Stelmachowska M; Stryczyński L; Golusiński W; Samara H; Mozer-Lisewska I; Zeromski J
    Eur Arch Otorhinolaryngol; 2007 May; 264(5):525-30. PubMed ID: 17165086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-Like Receptors (TLRs): The Role in Tumor Progression.
    Shcheblyakov DV; Logunov DY; Tukhvatulin AI; Shmarov MM; Naroditsky BS; Gintsburg AL
    Acta Naturae; 2010 Jul; 2(3):21-9. PubMed ID: 22649649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-Like Receptors (TLRs) in the Tumor Microenvironment (TME): A Dragon-Like Weapon in a Non-fantasy Game of Thrones.
    Angrini M; Varthaman A; Cremer I
    Adv Exp Med Biol; 2020; 1263():145-173. PubMed ID: 32588327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.